| First Author | Mastaitis J | Year | 2015 |
| Journal | Proc Natl Acad Sci U S A | Volume | 112 |
| Issue | 6 | Pages | 1845-9 |
| PubMed ID | 25624481 | Mgi Jnum | J:219560 |
| Mgi Id | MGI:5621200 | Doi | 10.1073/pnas.1424968112 |
| Citation | Mastaitis J, et al. (2015) GPR17 gene disruption does not alter food intake or glucose homeostasis in mice. Proc Natl Acad Sci U S A 112(6):1845-9 |
| abstractText | G protein-coupled receptor 17 (GPR17) was recently reported to be a Foxo1 target in agouti-related peptide (AGRP) neurons. Intracerebroventricular injection of GPR17 agonists induced food intake, whereas administration of an antagonist to the receptor reduced feeding. These data lead to the conclusion that pharmacological modulation of GPR17 has therapeutic potential to treat obesity. Here we report that mice deficient in Gpr17 (Gpr17(-/-)) have similar food intake and body weight compared with their wild-type littermates. Gpr17(-/-) mice have normal hypothalamic Agrp mRNA expression, AGRP plasma levels, and metabolic rate. GPR17 deficiency in mice did not affect glucose homeostasis or prevent fat-induced insulin resistance. These data do not support a role for GPR17 in the control of food intake, body weight, or glycemic control. |
